Novartis names Bulto as head of drugs business

Swiss drugmaker Novartis has named company veteran Victor Bulto as head of its US pharmaceuticals business, effective 1 September. The move comes as Novartis dismissed 2 top scientists for internal data falsification as it “violated FDA’s sacred principle“.